
Oncologist

No OPD information available
Breast Cancer
Endometrial Cancer
Lynch Syndrome
Ovarian Cancer
Turcot Syndrome
Brain Tumor
Colorectal Cancer
Kienbock's Disease
Ovarian Carcinosarcoma
Yoland C. Antill is a female medical professional who helps patients with different health issues like breast cancer, endometrial cancer, ovarian cancer, brain tumors, and more. She is skilled in treating conditions like Lynch Syndrome, Turcot Syndrome, Colorectal Cancer, Kienbock's Disease, and Ovarian Carcinosarcoma.
Yoland C. Antill provides care to patients using special skills and treatments tailored to their specific needs. She communicates with patients in a way that makes them feel understood and cared for, which helps build trust between them.
To stay updated with the latest medical knowledge and research, Yoland C. Antill regularly reads medical journals and attends conferences and workshops. This helps her provide the best possible care to her patients based on the most recent information available.
Yoland C. Antill works closely with other medical professionals, collaborating and sharing knowledge to ensure the best outcomes for patients. Her relationships with colleagues are important for providing comprehensive care and staying informed about new treatment options.
Through her work, Yoland C. Antill has positively impacted many patients' lives by providing effective treatments and compassionate care. Her dedication to improving patient outcomes and quality of life has made a significant difference in the health and well-being of those she treats.
One of Yoland C. Antill's notable publications is a study on patients' and doctors' preferences in early-stage triple-negative breast cancer treatment. She has also been involved in clinical trials, such as a study on a new treatment for HER2+ breast carcinoma, which has the potential to improve outcomes for patients with this type of cancer.
In summary, Yoland C. Antill is a dedicated and knowledgeable medical professional who uses her expertise to help patients facing various health challenges. Her commitment to staying informed, collaborating with colleagues, and conducting research contributes to the positive impact she has on patients' lives.
Enrollment Status: Completed
Published: August 14, 2023
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
